Chekkit Technologies helps you identify fake drugs by Nneka Chile

Startups in Nigeria are helping fight counterfeit pharmaceutical drugs in Africa’s most populous nation, where the prevalence rate of fake drugs is higher than the global average 10% and contributes to several deaths annually.

The most counterfeited are drugs for anti-malaria, pain and antibiotics, according to the National Agency for Food and Drug Administration and Control (NAFDAC).

To fight the flood of fake pills, the agency, in partnership with the startups has created stickers with unique codes that manufacturers and distributors can attach to boxes and sachets of pills. Consumers can then use apps on their phones to scan the code and confirm their authenticity.

Lagos-based Chekkit Technologies’ mobile app allows patients to check authenticity and enables manufacturers to see the number of new customers using their products.

“They’ve (manufacturers) also been able to discover things like side effects, potential side effects their product could have on consumers based on what people say about their product,” the company’s founder Dare Odumade told Reuters.

NAFDAC’s director of investigation and enforcement directorate Kingsley Ejiofor said the agency had in the past three years seized 2 trillion naira ($4.8 billion) worth of counterfeit drugs.

He said tracking apps were boosting the confidence of consumers.

“We currently have about 200 containers of counterfeit medicine at the ports scheduled for destruction. Just imagine the people that could have died as a result of use of such products,” Ejiofor said, adding that China and India were the major sources of the fake medicines.

At Sproxil Africa, a mobile authentication firm, Managing Director Chinedum Chijioke said the company’s app empowered users to validate the authenticity of products they were purchasing.

Biofem Industries imports pharmaceutical products and uses Sproxil technology, which has helped create more visible supply chain for its drugs and other fast-moving consumer goods, said Chief Executive Officer Femi Soremekun.

(Additional reporting by Fikayo Owoeye; Writing by MacDonald Dzirutwe; Editing by Lisa Shumaker)

Source. Reuters